- Q3 2026 revenue of $150.7 million, up 1% year-over-year from $149.0 million.
- Net loss for Q3 narrowed to -$19.4M (EPS -$0.15) from -$27.5M (EPS -$0.22) in Q3 2025.
- 9-month revenue dropped to $452.5M compared to $476.7M in the prior year period.
Signal #150010 · SEC 8-K
$TXG SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $TXG filing catalyst
Why did $TXG trigger an AI stock catalyst alert?
$TXG triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -2.0/10). Headline: 10x Genomics Q3 Revenue Flat at $150.7M, Reports $19.4M Net Loss. Key points: - Q3 2026 revenue of $150.7 million, up 1% year-over-year from $149.0 million. - Net loss for Q3 narrowed to -$19.4M (EPS -$0.15) from -$27.5M (EPS -$0.22) in Q3 2025. - 9-month revenue dropped to $452.5M compared to $476.7M in the prior year period.
How did $TXG stock react after the SEC filing?
After the SEC 8-K for $TXG, observed market reaction: T0 price $58.06. Past moves do not guarantee future results.
Where can I get real-time $TXG SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $TXG via Telegram and the VIP Web Terminal from €10/month.